A067370 Stock Overview
SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
SunBio,Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩8,780.00 |
52 Week High | ₩14,500.00 |
52 Week Low | ₩7,810.00 |
Beta | 0 |
1 Month Change | -3.41% |
3 Month Change | -9.58% |
1 Year Change | -26.22% |
3 Year Change | -75.37% |
5 Year Change | -42.49% |
Change since IPO | -20.66% |
Recent News & Updates
Recent updates
Shareholder Returns
A067370 | KR Biotechs | KR Market | |
---|---|---|---|
7D | 9.2% | 1.9% | 2.2% |
1Y | -26.2% | 6.5% | 5.4% |
Return vs Industry: A067370 underperformed the KR Biotechs industry which returned 6.5% over the past year.
Return vs Market: A067370 underperformed the KR Market which returned 5.4% over the past year.
Price Volatility
A067370 volatility | |
---|---|
A067370 Average Weekly Movement | 4.9% |
Biotechs Industry Average Movement | 8.3% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.7% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A067370 has not had significant price volatility in the past 3 months.
Volatility Over Time: A067370's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | n/a | n/a | www.sunbio.com |
SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.
SunBio,Inc. Fundamentals Summary
A067370 fundamental statistics | |
---|---|
Market cap | ₩108.11b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A067370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A067370 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A067370 perform over the long term?
See historical performance and comparison